Mutations in oxyR and oxyR-ahpC Interogenic Region in Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Chongqing, China.

Infect Drug Resist · 2026 · PMC12998331 · PMID 41859070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

A clear trend was observed in our study, where the proportion of katG 315 mutations in MDR (93.97%) and Pre-XDR/XDR (91.67%) isolates was significantly higher than that in INH-monoresistant (69.23%) isolates.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Mutations in &lt;i&gt;oxyR&lt;/i&gt; and &lt;i&gt;oxyR-ahpC&lt;/i&gt; Interogenic Region in Isoniazid-Resistant &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; Clinical Isolates from Chongqing, China.

The sentences

Mutations in <i>oxyR</i> and <i>oxyR-ahpC</i> Interogenic Region in Isoniazid-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates from Chongqing, China.